Metformin Effect on Brain Function in Insulin Resistant Elderly People

Summary

Alzheimer's disease (AD) and other forms of dementia are rapidly increasing with the aging of the population, and show a clear preponderance among people with insulin resistance. Metformin, an insulin sensitizer, is being examined in clinical trials as an anti-aging drug. However, very little objective data is available regarding metformin's effect on the brain, a major organ affected by aging.

Timeline

Start

2019-03-15

Primary completion

2023-04-05

Completion

2023-04-05

Drugs

Indications